Clinical Review

Preventing fragility fractures: Effective drugs and doses

OBG Manag. 2005 November;17(11):54-58
Author and Disclosure Information
PDF Download

 

Dr. Goldstein reports that he serves on the gynecology advisory boards for Eli Lilly, Merck, Pfizer, Procter & Gamble, and TAP Pharmaceuticals.

Pages

Recommended Reading

Successful Cholecystectomy During Pregnancy
MDedge ObGyn
DIV May Underlie Chronic Vaginal Symptoms
MDedge ObGyn
Try Plastic Wrap to Improve Estrogen Delivery
MDedge ObGyn
Study Links Melatonin to IBS Improvement
MDedge ObGyn
Study Explores Laparoscopic Ligation of Varicosities
MDedge ObGyn
Study Supports Treating the Bladder Component of Pelvic Pain
MDedge ObGyn
Warn About Risk of Irritative Bladder Symptoms After TVT
MDedge ObGyn
Digital Mammography Best for Some Women
MDedge ObGyn
Addition of Herceptin to Chemo Is Linked to Increased Cardiotoxicity
MDedge ObGyn
BRCA-Negative Breast Cancer Does Not Raise Ovarian Risk
MDedge ObGyn